Article Information
PubMed
Published By
Online ISSN
History
- Published online March 5, 2015.
Article Versions
- Previous version (January 27, 2015 - 19:33).
- Previous version (January 28, 2015 - 21:31).
- You are viewing the most recent version of this article.
Copyright & Usage
© Barnhart et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: http://dx.doi.org/10.9745/GHSP-D-14-00243.
Author Information
- Matthew Barnharta,
- James D Sheltonb
- aGlobal Health: Science and Practice, Associate Editor.
- bGlobal Health: Science and Practice, Editor-in-Chief.
- Correspondence to Matthew Barnhart (mbarnhart{at}ghspjournal.org).
Statistics from Altmetric.com
Article usage
In this issue
Statistics from Altmetric.com
Jump to section
- Article
- THE CRUCIAL NEED FOR BETTER ANTIRETROVIRAL THERAPY, ESPECIALLY FOR HIGH-BURDEN COUNTRIES
- DOLUTEGRAVIR: A POTENTIAL “GAME-CHANGER” FOR BETTER ARV REGIMENS
- REDUCING TO JUST 2 ARVS AT A TIME: A SIMPLER APPROACH
- IMPROVED SECOND-LINE COMBINATIONS WITH DOLUTEGRAVIR
- LONG-ACTING INJECTABLE ARVS
- JOINT ACTION NEEDED TOWARD BETTER ARV REGIMENS
- CONCLUSION
- Acknowledgments
- Footnotes
- Notes
- REFERENCES
- Figures & Tables
- Info & Metrics
- Comments